Denise Sheer

Last updated

Denise Sheer
Born
Alma mater University of Oxford
Known forCancer Genetics, Genome Biology
Scientific career
Fields Human Genetics
InstitutionsInstitute of Cell and Molecular Science, Barts and The London, Queen Mary's School of Medicine and Dentistry

Denise Sheer was appointed professor of human genetics at The Institute of Cell and Molecular Science at Queen Mary, University of London in November 2006. Her fields of expertise include cell and molecular biology; cancer genetics and epigenetics; and molecular pathology of paediatric brain tumours.

Contents

Education and career

Sheer completed a BSc (Hons) degree in embryology and zoology at the University of the Witwatersrand, Johannesburg in 1973, after which she ran the diagnostic cytogenetics laboratory at the South African Institute of Medical Research for two years. [1]

She then moved to the genetics laboratory of the University of Oxford, where she was awarded a D.Phil. in 1980. She completed a post-doctoral research fellowship at the Imperial Cancer Research Fund (now the Cancer Research UK London Research Institute) and became head of the Human Cytogenetics Laboratory from 1983 to 2006. Here her work involved the identification of significant genetic aberrations in many malignant cancers and she made critical discoveries on chromosome architecture. [1]

In 2006 she moved with her research group to the Blizard Institute in the Centre for Genomics and Child Health at Barts and The London, Queen Mary's School of Medicine and Dentistry. [2]

The Blizard Building. QMUL-Blizard-building.jpg
The Blizard Building.

Her current research is an interventional clinical trial studying the treatment of young patients with recurrent or refractory low grade glioma, due for completion in 2020. [3] [4] The group received the Jeremy Jass Prize for Excellence in Pathology for this work [5] .

Glioma of the left parietal lobe. CT scan with contrast enhancement. Glioma.gif
Glioma of the left parietal lobe. CT scan with contrast enhancement.

Sheer has 273 publications and 11,000 citations listed on ResearchGate and almost 15,000 citations listed on Google Scholar. The work done by Sheer and her group has been funded by The Brain Tumour Charity since 2013 [6] and she won the Research Engagement Award at The Brain Tumour Charity Celebrating You Awards [7]

Related Research Articles

<span class="mw-page-title-main">Barts and The London School of Medicine and Dentistry</span> Medical and dental school in London, England

Barts and The London School of Medicine and Dentistry, commonly known as Barts or BL, is a medical and dental school in London, England. The school is part of Queen Mary University of London, a constituent college of the federal University of London, and the United Hospitals. It was formed in 1995 by the merger of the London Hospital Medical College and the Medical College of St Bartholomew's Hospital.

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.

<span class="mw-page-title-main">The Brain Tumour Charity</span> British charity founded in 1996

The Brain Tumour Charity is a UK-based, Charity Commission registered, charity dedicated to funding research, raising awareness of brain tumours, reducing diagnosis times and providing support and information for people with brain tumours, their families and friends.

<span class="mw-page-title-main">London Research Institute</span> Biological research facility

The Cancer Research UK London Research Institute (LRI) was a biological research facility which conducted research into the basic biology of cancer.

<span class="mw-page-title-main">Hani Gabra</span>

Hani Gabra PhD FRCPE FRCP is a British oncologist and Professor Emeritus in Medical Oncology at Imperial College London.

The Atlas of Genetics and Cytogenetics in Oncology and Haematology, created in 1997 by Jean-Loup Huret is a collection of resources on genes, chromosomes anomalies, leukemias, solid tumours, and cancer-prone diseases. The project is accessible through Internet and is made of encyclopedic-style files, as well as traditional overviews, links towards websites and databases devoted to cancer and/or genetics, case reports in haematology. It also encompasses teaching items in various languages.

<span class="mw-page-title-main">Diffuse midline glioma</span> Highly aggressive brain tumor, mostly found in children

Diffuse midline glioma, H3 K27-altered (DMG) is a fatal tumour that arises in midline structures of the brain, most commonly the brainstem, thalamus and spinal cord. When located in the pons it is also known as diffuse intrinsic pontine glioma (DIPG).

<span class="mw-page-title-main">Parveen Kumar</span> Indian academic

Dame Parveen June Kumar is a British doctor who is currently Professor of Medicine and Education at Barts and The London School of Medicine and Dentistry. She worked in the NHS for over 40 years as a consultant gastroenterologist and physician at Barts and the London Hospitals and the Homerton University Hospital. She was the President of the British Medical Association in 2006, of the Royal Society of Medicine from 2010 to 2012, of the Medical Women's Federation from 2016 to 2018 and of the Royal Medical Benevolent Fund from 2013 to 2020. She was also Vice President of the Royal College of Physicians from 2003 to 2005. In addition, she was a founding non-executive director of the National Institute of Clinical Excellence, chaired the Medicines Commission UK until 2005, and also chaired the BUPA Foundation Charity for Research until 2013.

<span class="mw-page-title-main">James Rutka</span> Canadian neurosurgeon

James Rutka is a Canadian neurosurgeon from Toronto, Canada. Rutka served as RS McLaughlin Professor and Chair of the Department of Surgery in the Faculty of Medicine at the University of Toronto from 2011 – 2022. He subspecializes in pediatric neurosurgery at The Hospital for Sick Children (SickKids), and is a Senior Scientist in the Research Institute at SickKids. His main clinical interests include the neurosurgical treatment of children with brain tumours and epilepsy. His research interests lie in the molecular biology of human brain tumours – specifically in the determination of the mechanisms by which brain tumours grow and invade. He is the Director of the Arthur and Sonia Labatt Brain Tumour Research Centre at SickKids, and Editor-in-Chief of the Journal of Neurosurgery.

<span class="mw-page-title-main">Brain Tumour Research</span>

Brain Tumour Research is a UK-based medical research charity dedicated to funding research, raising awareness of brain tumours. The charities vision is to find a cure for brain tumours of all kinds.

Irene May Leigh CBE FRSE FMedSci is a British dermatologist. A former professor of Barts and The London School of Medicine and Dentistry, she is now a professor emeritus at the University of Dundee School of Medicine. Her research has focused on keratinocytes, non-melanoma skin cancers and genetic skin diseases. She was elected to the Academy of Medical Sciences in 1999 and appointed CBE in 2012.

Ren Michael Pedersen is an advocate for children's brain cancer research.

<span class="mw-page-title-main">Children's Cancer Foundation (Australia)</span>

The Children's Cancer Foundation is a registered Australian charity that supports children with cancer and their families.

<span class="mw-page-title-main">Kairbaan Hodivala-Dilke</span> Cell biologist

Kairbaan Hodivala-Dilke, FMedSci is an English cell biologist who has made significant contributions to the understanding of the cellular and molecular biology of the tumour microenvironment and in particular angiogenesis. She is Professor of Angiogenesis and the Tumour Microenvironment and Deputy Institute Director of Barts Cancer Institute, Queen Mary University of London. In 2015 she was awarded the Hooke medal from the British Society for Cell Biology and EMBO membership.

<span class="mw-page-title-main">Michelle Monje</span> American neurologist and researcher

Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma.

Sir Mark Jonathan Caulfield MD, FRCP, FESC, FPharm, FBHS, FMedSci (born 19 July 1960) is a British genomic medicine researcher and Warden of Barts and The London School of Medicine and Dentistry. He is the Professor of Clinical Pharmacology at the William Harvey Research Institute in Queen Mary University of London. He was awarded a knighthood in the 2019 Birthday Honours.

<span class="mw-page-title-main">Sarah Coupland</span> Australian clinical pathologist

Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.

Victoria Sanz Moreno is a Spanish scientist. She is professor of cancer cell and metastasis biology at The Institute of Cancer Research.

<span class="mw-page-title-main">Yardena Samuels</span> Israeli molecular biologist

Yardena Samuels or Samuels-Lev is an Israeli molecular biologist who is the Director of the Ekard Institute for Cancer Diagnosis Research at the Weizmann Institute of Science. Her research considers the genetic mutations of melanoma.

References

  1. 1 2 "Professor Denise Sheer BSc (Hons). D.Phil". Institute of Cell and Molecular Science. The Wayback Machine: Barts and The London, Queen Mary's School of Medicine and Dentistry. Archived from the original on 2 June 2009. Retrieved 19 February 2019.
  2. "Sheer, Denise – Blizzard Institute". Blizzard Institute. Barts and The London School of Medicine and Dentistry. Archived from the original on 20 June 2019. Retrieved 19 February 2019.
  3. National Cancer Institute. "Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma". ClinicalTrials.gov. US National Library of Medicine. Retrieved 19 February 2019.
  4. "AstroFund – Sheer Research". astrofund.org. Retrieved 19 February 2019.
  5. "AstroFund – Research". astrofund.org. Retrieved 19 February 2019.
  6. The Brain Tumour Charity (March 2013). Professor Denise Sheer, March 2013 – YouTube (YouTube). Retrieved 19 February 2019.
  7. The Brain Tumour Charity (27 June 2018). The Research Engagement Award – Professor Denise Sheer – YouTube (YouTube). Retrieved 19 February 2019.